Form 4 · Filed Mar 5, 2026, 12:00 PM UTC
NVAX/NOVAVAX INC
Draghia-Akli Ruxandra — EVP, Research & Development
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
5 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 3, 2026 | M | other | 26,667 | $0 | $0 | 34,876 |
| Mar 3, 2026 | F | other | 11,313 | $9 | $107,360 | 23,563 |
| Mar 3, 2026 | D | other | 26,667 | $0 | — | 53,333 |
| Mar 2, 2026 | A | other | 93,000 | $0 | — | 101,000 |
| Mar 2, 2026 | A | other | 139,500 | $9 | $1,268,055 | 139,500 |
Source: SEC EDGAR raw filing ↗ · Accession 0001104659-26-023709